Pharma Mar, S.A.
Pharma Mar, S.A. (PHMMF) Stock Overview
Explore Pharma Mar, S.A.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.5B
P/E Ratio
38.40
EPS (TTM)
$2.30
ROE
0.17%
PHMMF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Pharma Mar, S.A. (PHMMF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 46.42, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $133.79.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 38.40 and a market capitalization of 1.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.